DrugPatentWatch Database Preview
Drugs in Development Information for IMC-1C11
Summary for IMC-1C11
| US Patents | 12 |
| International Patents | 117 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2015-09-01) |
| Vendors | 0 |
US Patents for IMC-1C11
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| IMC-1C11 | ➤ Sign Up | Method and compositions for treating cancerous tumors | ➤ Sign Up | |
| IMC-1C11 | ➤ Sign Up | Quinolines derivatives as novel anticancer agents | GENOSCIENCE PHARMA (Marseilles, FR) | ➤ Sign Up |
| IMC-1C11 | ➤ Sign Up | Oxidized carotenoid fractions and ketoaldehyde useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents | Chemaphor Inc. (Ontario, CA) | ➤ Sign Up |
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
International Patents for IMC-1C11
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| IMC-1C11 | Australia | 2014233757 | 2033-03-18 | ➤ Sign Up |
| IMC-1C11 | Brazil | 112015023948 | 2033-03-18 | ➤ Sign Up |
| IMC-1C11 | Canada | 2902734 | 2033-03-18 | ➤ Sign Up |
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
